Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMAM | RXRX | SRPT | ||
| Company | Ambrx Biopharma Inc ADR | Recursion Pharmaceuticals Inc Cl A | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.99 | 3.39 | 16.65 | ||
| High | 28.00 | 3.46 | 17.33 | ||
| Low | 27.98 | 3.39 | 16.65 | ||
| Latest | 28.00 | 3.44 | 17.20 | ||
| Change | +0.02 | +0.05 | +0.54 | ||
| % Change | +0.07% | +1.47% | +3.24% | ||
| Volume | 1,439,600 | 1,078,575 | 239,749 | ||
| 20-Day Average Volume | 1,545,680 | 16,709,662 | 2,363,629 | ||
| Previous Close | 27.98 | 3.39 | 16.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.86 | 3.53 | 17.37 | ||
| 20-Day Raw Stochastic | 94.23% | 41.36% | 47.38% | ||
| 20-Day Relative Strength | 80.97 | 42.24 | 45.23 | ||
| Weighted Alpha | +89.90 | -51.26 | -45.48 | ||
| Today's Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 02/28/24 | -0.15% since 03/10/26 | -2.10% since 03/10/26 | ||
| Low | 27.93 on 03/01/24 | 3.22 on 03/12/26 | 16.27 on 03/16/26 | ||
| High | 28.00 on 03/06/24 | 3.56 on 03/11/26 | 17.59 on 03/13/26 | ||
| 1-Month | |||||
| %Chg | +0.79% since 02/06/24 | -0.72% since 02/17/26 | -3.30% since 02/17/26 | ||
| Low | 27.51 on 02/20/24 | 2.98 on 02/18/26 | 15.52 on 03/06/26 | ||
| High | 28.03 on 02/26/24 | 4.08 on 02/25/26 | 19.25 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +132.75% since 12/06/23 | -26.60% since 12/17/25 | -18.21% since 12/17/25 | ||
| Low | 11.74 on 12/12/23 | 2.98 on 02/18/26 | 15.52 on 03/06/26 | ||
| High | 28.15 on 01/10/24 | 5.24 on 01/22/26 | 24.68 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +111.32% since 09/06/23 | -27.07% since 09/17/25 | +1.41% since 09/17/25 | ||
| Low | 6.55 on 10/23/23 | 2.98 on 02/18/26 | 15.08 on 11/04/25 | ||
| High | 28.15 on 01/10/24 | 7.18 on 10/20/25 | 25.32 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,768,200 | 1,787,879 | 1,749,133 | ||
| Shares Outstanding, K | 63,150 | 527,398 | 104,990 | ||
| Annual Sales | 7,400,000 | 74,680,000 | 2,198,240,000 | ||
| Annual Net Income | -78,000,000 | -644,760,000 | -713,410,000 | ||
| Last Quarter Sales | 1,120,000 | 35,540,000 | 442,930,000 | ||
| Last Quarter Net Income | -17,830,000 | -108,120,000 | -282,850,000 | ||
| 60-Month Beta | -1.92 | 0.97 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/09/23 | -0.21 on 02/25/26 | -3.58 on 02/25/26 | ||
| Latest Earnings Date | 04/04/24 | 05/04/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||